Price to Sales ratio Analysis of Heron Therapeuti - Deep Dive


Latest FY PS
Period Ending - Dec-23

0.0036


Excellent PS
Period Ending - Dec-22
3.24

Very Poor PS
Growth
-99.89 %
Trailing Twelve Months PS
Period Ending - Dec-23

3.43


Very Poor PS
PS Analysis of Heron Therapeuti
P/S Ratio of Heron Therapeuti with value of 3.43 indicates that stock price is high compared to sales of the company and may be overvalued.
PS Ratio of HRTX drastically fell by -99.89 % this year.
PS Ratio with value of 3.61 was highest in Year Dec-21 in last Five Years.
PS Ratio with value of 0.0036 was lowest in Year Dec-23 in last Five Years.
Latest PS Ratio with value of 0.0036 is lower than Average PS of 2.38 in last five years.
Other PS Related Info of HRTX that may interest you.
Heron Therapeuti Overview
CodePricePrevious PricePrice ChangeSector
HRTX3.23.22 0.621 % Biotechnology
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
Poor Value Stock
FY - Historical Price to Sales of Heron Therapeuti
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
PS0.00363.243.613.281.793.025.62
Change-99.89 %-10.48 %10.29 %82.79 %-40.70 %-46.21 %-94.08 %
You are view first 7 Records. Log in to view all 37 in Premium view
FY Chart of Price to Sales of Heron Therapeuti


Note : All Data Generated at the End of Trading Hours (EOD Data)